Raymond James & Associates’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-33,800
Closed -$79K 3433
2017
Q1
$79K Sell
33,800
-800
-2% -$101K ﹤0.01% 3102
2016
Q4
$26K Buy
+34,600
New +$3.98M ﹤0.01% 3133

Other funds holding SYK

Raymond James & Associates's SYK Position: Q3 2024 in Review

Raymond James & Associates increased its Stryker (SYK) stake by 24% in Q3 2024, buying an estimated $47.6M and bringing the position to 724,533 shares worth $262M. The position accounts for 0.16% of the portfolio, ranked #106.

Raymond James & Associates first reported a position in SYK in Q2 2013 and has held it in 46 quarters since. 2,034 funds tracked by Wall St. Rank hold SYK as of Q3 2024.

  • Raymond James & Associates held 724,533 shares of Stryker worth $262M as of Q3 2024.
  • Raymond James & Associates bought 137,916 Stryker shares in Q3 2024, an estimated $47.6M.
  • Stryker made up 0.16% of Raymond James & Associates's portfolio in Q3 2024, its #106 holding.
  • Raymond James & Associates first reported a position in Stryker in Q2 2013 and has held it in 46 quarters since.
  • 2,034 funds tracked by Wall St. Rank held Stryker as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.